Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8914846rdf:typepubmed:Citationlld:pubmed
pubmed-article:8914846lifeskim:mentionsumls-concept:C0079870lld:lifeskim
pubmed-article:8914846lifeskim:mentionsumls-concept:C0524637lld:lifeskim
pubmed-article:8914846lifeskim:mentionsumls-concept:C0002860lld:lifeskim
pubmed-article:8914846lifeskim:mentionsumls-concept:C0020364lld:lifeskim
pubmed-article:8914846lifeskim:mentionsumls-concept:C1709915lld:lifeskim
pubmed-article:8914846lifeskim:mentionsumls-concept:C1710236lld:lifeskim
pubmed-article:8914846lifeskim:mentionsumls-concept:C0037791lld:lifeskim
pubmed-article:8914846lifeskim:mentionsumls-concept:C1554080lld:lifeskim
pubmed-article:8914846lifeskim:mentionsumls-concept:C1706198lld:lifeskim
pubmed-article:8914846lifeskim:mentionsumls-concept:C0521115lld:lifeskim
pubmed-article:8914846lifeskim:mentionsumls-concept:C0010772lld:lifeskim
pubmed-article:8914846pubmed:issue1lld:pubmed
pubmed-article:8914846pubmed:dateCreated1996-12-24lld:pubmed
pubmed-article:8914846pubmed:abstractTextBased on recent studies of single reciprocal mutants of cytochrome P450 2B4 and the highly related P450 2B5 at positions 114, 294, 363, and 367 [G. D. Szklarz, Y. Q. He, K. M. Kedzie, J. R. Halpert, and V. L. Burnett (1996) Arch. Biochem. Biophys. 327,308-318], a number of multiple mutants were constructed, expressed in Escherichia coli, and assayed with androstenedione, progesterone, and benzyloxyresorufin. Simultaneous substitutions of Ile-114, Ser-294, Ile-363, and Val-367 in cytochrome P450 2B4 with Phe, Thr, Val, and Ala, respectively from 2B5, resulted in a marked increase in androstenedione 15alpha- and 16alpha-hydroxylation compared with the wild-type enzyme and yielded a metabolite profile indistinguishable from that of cytochrome P450 2B5. Likewise, the reciprocal P450 2B5 quadruple mutant exhibited the specificity for 16beta-hydroxylation characteristic of the 2B4 wild type. The two reciprocal quadruple mutants of P450 2B4 and 2B5 also displayed benzyloxyresorufin dealkylase activities similar to those of the wild-type P450 2B5 and 2B4, respectively. However, the progesterone metabolite profile of P450 2B5 was not identical to that of the 2B4 quadruple mutant or of a quintuple mutant in which residue 370 was also mutated to the 2B5 residue. Therefore, the 17beta-acetyl group on progesterone as opposed to the oxo group on androstenedione may lead to interaction with additional amino acid residues.lld:pubmed
pubmed-article:8914846pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8914846pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8914846pubmed:languageenglld:pubmed
pubmed-article:8914846pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8914846pubmed:citationSubsetIMlld:pubmed
pubmed-article:8914846pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8914846pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8914846pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8914846pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8914846pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8914846pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8914846pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8914846pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8914846pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8914846pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8914846pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8914846pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8914846pubmed:statusMEDLINElld:pubmed
pubmed-article:8914846pubmed:monthNovlld:pubmed
pubmed-article:8914846pubmed:issn0003-9861lld:pubmed
pubmed-article:8914846pubmed:authorpubmed-author:HeY QYQlld:pubmed
pubmed-article:8914846pubmed:authorpubmed-author:HalpertJ RJRlld:pubmed
pubmed-article:8914846pubmed:authorpubmed-author:SzklarzG DGDlld:pubmed
pubmed-article:8914846pubmed:issnTypePrintlld:pubmed
pubmed-article:8914846pubmed:day1lld:pubmed
pubmed-article:8914846pubmed:volume335lld:pubmed
pubmed-article:8914846pubmed:ownerNLMlld:pubmed
pubmed-article:8914846pubmed:authorsCompleteYlld:pubmed
pubmed-article:8914846pubmed:pagination152-60lld:pubmed
pubmed-article:8914846pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:8914846pubmed:meshHeadingpubmed-meshheading:8914846-...lld:pubmed
pubmed-article:8914846pubmed:meshHeadingpubmed-meshheading:8914846-...lld:pubmed
pubmed-article:8914846pubmed:meshHeadingpubmed-meshheading:8914846-...lld:pubmed
pubmed-article:8914846pubmed:meshHeadingpubmed-meshheading:8914846-...lld:pubmed
pubmed-article:8914846pubmed:meshHeadingpubmed-meshheading:8914846-...lld:pubmed
pubmed-article:8914846pubmed:meshHeadingpubmed-meshheading:8914846-...lld:pubmed
pubmed-article:8914846pubmed:meshHeadingpubmed-meshheading:8914846-...lld:pubmed
pubmed-article:8914846pubmed:meshHeadingpubmed-meshheading:8914846-...lld:pubmed
pubmed-article:8914846pubmed:meshHeadingpubmed-meshheading:8914846-...lld:pubmed
pubmed-article:8914846pubmed:meshHeadingpubmed-meshheading:8914846-...lld:pubmed
pubmed-article:8914846pubmed:meshHeadingpubmed-meshheading:8914846-...lld:pubmed
pubmed-article:8914846pubmed:meshHeadingpubmed-meshheading:8914846-...lld:pubmed
pubmed-article:8914846pubmed:meshHeadingpubmed-meshheading:8914846-...lld:pubmed
pubmed-article:8914846pubmed:meshHeadingpubmed-meshheading:8914846-...lld:pubmed
pubmed-article:8914846pubmed:meshHeadingpubmed-meshheading:8914846-...lld:pubmed
pubmed-article:8914846pubmed:meshHeadingpubmed-meshheading:8914846-...lld:pubmed
pubmed-article:8914846pubmed:meshHeadingpubmed-meshheading:8914846-...lld:pubmed
pubmed-article:8914846pubmed:meshHeadingpubmed-meshheading:8914846-...lld:pubmed
pubmed-article:8914846pubmed:meshHeadingpubmed-meshheading:8914846-...lld:pubmed
pubmed-article:8914846pubmed:meshHeadingpubmed-meshheading:8914846-...lld:pubmed
pubmed-article:8914846pubmed:meshHeadingpubmed-meshheading:8914846-...lld:pubmed
pubmed-article:8914846pubmed:meshHeadingpubmed-meshheading:8914846-...lld:pubmed
pubmed-article:8914846pubmed:year1996lld:pubmed
pubmed-article:8914846pubmed:articleTitleInterconversion of the androstenedione hydroxylase specificities of cytochromes P450 2B4 and 2B5 upon simultaneous site-directed mutagenesis of four key substrate recognition residues.lld:pubmed
pubmed-article:8914846pubmed:affiliationDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson 85721, USA.lld:pubmed
pubmed-article:8914846pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8914846pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:8914846pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8914846lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8914846lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8914846lld:pubmed